-
Boehringer Ingelheim convenes “Detect the SOS” Collective for public health mission: increase uACR screening among adults with type 2 diabetes and/or high blood pressure to help uncover kidney damage and elevated heart risks
28 Jan 2026 13:35 GMT
… multivu.com/boehringer-ingelheim/9369051-en-boehringer-ingelheim-detect-the-sos- … the potential to improve.
Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active … . Our approximately 54,500 employees serve over 130 markets to …
-
Boehringer Ingelheim’s investigational asset apecotrep delivers proteinuria reduction in Phase II kidney trial
28 Jan 2026 05:35 GMT
… Unit, Board of Managing Directors, Boehringer Ingelheim. “With the Phase III trial … as TRPC6.12,13 About Boehringer Ingelheim Boehringer Ingelheim is a biopharmaceutical company active … chain. Our approximately 54,500 employees serve over 130 markets to …
-
Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease
27 Jan 2026 08:40 GMT
… China, 26, January 2026 – Boehringer Ingelheim and Simcere Pharmaceutical Group Ltd … the Greater China territory.
Boehringer Ingelheim Boehringer Ingelheim is a biopharmaceutical company active … Our approximately 54,500 employees serve over 130 markets to …
-
Business News | Boehringer Ingelheim India Announces Partnership with Alivira Animal Health Limited
23 Jan 2026 07:00 GMT
… Mumbai (Maharashtra) [India], January 23: Boehringer Ingelheim India Private Limited has entered … | 8th Pay Commission Latest Update: Employee Bodies to Meet Soon to … on-ground capabilities, combined with Boehringer Ingelheim's differentiated companion …
-
Viyash Scientific partners with Boehringer Ingelheim to sell its companion animal products in India
22 Jan 2026 17:54 GMT
With over 3,000 employees, Viyash Scientific Limited’s portfolio … on-ground capabilities combined with Boehringer Ingelheim’s differentiated companion animal product … reach.”
With over 3,000 employees, Viyash Scientific Limited’s portfolio …
-
HONORable Mentions: Summer and Fall 2025
05 Feb 2026 19:46 GMT
… ’s internships at Fiserv and Boehringer Ingelheim in the past semesters has … , developing risk assessment tools and employee assessments to improve efficiency and …
-
Boehringer Ingelheim earns 'Top Employer' status
16 Jan 2026 12:43 GMT
… development
Beyond well-being, employees benefit from tailored lifelong learning … . For example, the internal Boehringer Ingelheim University makes a virtual campus … 's recognition programmes, employee listening mechanisms, and engagement initiatives …
-
Boehringer Ingelheim obtains two EU CVMP positive opinions for avian influenza vaccines VAXXITEK® HVT+IBD+H5 and VAXXINACT® H5
20 Nov 2025 11:05 GMT
… , 2025)
Boehringer Ingelheim - Animal Health business Boehringer Ingelheim provides innovation … at www.boehringer-ingelheim.com/animal-health. Boehringer Ingelheim Boehringer Ingelheim is a … Our approximately 54,500 employees serve over 130 markets …
-
Boehringer Ingelheim and CDR-Life Expand Collaboration Efforts with Global Licensing Agreement for CDR111, an Antibody-Based Trispecific M-gager® for Autoimmune Diseases
04 Nov 2025 13:00 GMT
… on future sales. About Boehringer Ingelheim Boehringer Ingelheim is a biopharmaceutical company … Our approximately 54,500 employees serve over 130 markets … life.com.
Boehringer Ingelheim Contact: Dr. Reinhard Malin
Boehringer Ingelheim Corporate Center …
-
Boehringer Ingelheim acquires license from Kyowa Kirin aimed at developing a novel treatment for patients with autoimmune diseases
30 Oct 2025 06:40 GMT
… on possible sales.
Boehringer Ingelheim Boehringer Ingelheim is a biopharmaceutical company … Our approximately 54,500 employees serve over 130 markets … Media Contacts Boehringer Ingelheim:
Dr. Reinhard Malin
Boehringer Ingelheim Corporate Center GmbH …
About
© 1995-2026